TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7386343

Group type: EXPERIMENTAL
Intervention: 167 mg of citrated caffeine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 324 mg of citrated caffeine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 500 mg of citrated caffeine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (0 mg of caffeine)
Number of subjects: 25
Study: 31551249

Group type: EXPERIMENTAL
Intervention: HDV-insulin lispro (HDV-L)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Insulin lispro (LIS)
Number of subjects: 176
Study: 27797928

Group type: COMPARATOR
Intervention: High-Carbohydrate Diet (HCD)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LCD)
Number of subjects: 10
Study: 25494832

Group type: EXPERIMENTAL
Intervention: Gain-frame message
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loss-frame message
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control message
Number of subjects: 0
Study: 22796543

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airways (LMA) and EZ-IO drill kit
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard methods of endotracheal intubation (ETI) and central line placement
Number of subjects: 44
Study: 21295901

Group type: EXPERIMENTAL
Intervention: Color singleton distractors in the left visual hemifield
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Color singleton distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Easier to detect target
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-salient distractor
Number of subjects: 0
Study: 19393928

Group type: EXPERIMENTAL
Intervention: Manipulation of the shoulder under anaesthetic
Number of subjects: 53

Group type: COMPARATOR
Intervention: Intra-articular shoulder injections using steroid with distension
Number of subjects: 53
Study: 16675705

Group type: EXPERIMENTAL
Intervention: Serogroup C glycoconjugate vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plain polysaccharide vaccine
Number of subjects: 0
Study: 12934956

Group type: EXPERIMENTAL
Intervention: Real millimeter wave therapy (MWT) sessions, n=4
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham sessions, n=4
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Electromagnetic millimeter waves in a random cross-over manner, n=4
Number of subjects: 12
Study: 10928302

Group type: EXPERIMENTAL
Intervention: Long-acting calcium channel blockers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8623869

Group type: EXPERIMENTAL
Intervention: Heavy colonization with group B streptococci
Number of subjects: 13646

Group type: EXPERIMENTAL
Intervention: Antibiotics effective against group B streptococci
Number of subjects: 13646

Group type: EXPERIMENTAL
Intervention: Light colonization with group B streptococci
Number of subjects: 13646

Group type: COMPARATOR
Intervention: Group B streptococci colonization at 23 to 26 weeks' gestation
Number of subjects: 13646

Group type: COMPARATOR
Intervention: Group B streptococci colonization at delivery
Number of subjects: 13646
Study: 1549403

Group type: EXPERIMENTAL
Intervention: Haemophilus influenzae type b Neisseria meningitidis outer membrane protein conjugate vaccine (PedvaxHIB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 4001836

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of porcine GIP at a dose of 1.0 microgram . kg‐1 . h‐1
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard breakfast
Number of subjects: 6
Study: 31707844

Group type: EXPERIMENTAL
Intervention: Facilitated family case conferencing
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Facility policy not to rotate personnel through dementia units
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Designation of nursing manager or registered/enrolled nurse
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Tertiary level of education
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Greater experience in dementia care
Number of subjects: 290
Study: 31895319

Group type: EXPERIMENTAL
Intervention: Qualitative study with victim families
Number of subjects: 145
Study: 29979421

Group type: EXPERIMENTAL
Intervention: Preoperative injection of carbon nanoparticles (CNs)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Intraoperative injection of carbon nanoparticles (CNs)
Number of subjects: 102
Study: 26890267

Group type: EXPERIMENTAL
Intervention: Intravenous preemptive analgesia (IV-PCA) with fentanyl started before skin incision
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (IV-PCA with fentanyl started 5 min after skin incision)
Number of subjects: 51
Study: 24528331

Group type: EXPERIMENTAL
Intervention: warfarin transitioned to rivaroxaban 20 mg once daily (group A)
Number of subjects: 96

Group type: COMPARATOR
Intervention: warfarin followed by placebo once daily (group B)
Number of subjects: 96

Group type: COMPARATOR
Intervention: rivaroxaban alone 20 mg once daily (group C)
Number of subjects: 96
Study: 22222996

Group type: EXPERIMENTAL
Intervention: LipiFlow treatment (12 minutes)
Number of subjects: 139

Group type: COMPARATOR
Intervention: iHeat Warm Compress (5 minutes daily for 2 weeks)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: LipiFlow treatment (12 minutes) in crossover group
Number of subjects: 139

Group type: COMPARATOR
Intervention: LipiFlow and iHeat WC
Number of subjects: 139
Study: 21144938

Group type: EXPERIMENTAL
Intervention: Reamer Irrigator Aspirator (RIA)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard Reaming (SR)
Number of subjects: 19
Study: 17662577

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 51

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 51

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 51
Study: 15630071

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 12198044

Group type: EXPERIMENTAL
Intervention: Sufentanil target concentration (STC) 0.1 ng/mL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sufentanil target concentration (STC) 0.2 ng/mL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sufentanil target concentration (STC) 0.3 ng/mL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Propofol target concentration 5.0 microg/mL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Propofol target concentration 4.0 microg/mL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Propofol target concentration 2.5 microg/mL
Number of subjects: 45
Study: 11575576

Group type: COMPARATOR
Intervention: Low group (160 g of tomato juice plus 320 g of control drink)
Number of subjects: 31

Group type: COMPARATOR
Intervention: High group (480 g of tomato juice)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (480 g of control drink)
Number of subjects: 31
Study: 9551876

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 228

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 228
Study: 8141442

Group type: EXPERIMENTAL
Intervention: Fentanyl/midazolam (1 mg/25 mg; dosage 0.1 ml/kg/h)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ketamine/midazolam (250 mg/25 mg; dosage 0.1 ml/kg/h)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Enflurane (mean concentration 1.5 vol%)
Number of subjects: 45
Study: 2900980

Group type: EXPERIMENTAL
Intervention: Group A (n = 53) - second-look laparotomy followed by cyclical oral chlorambucil
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Group B (n = 56) - second-look laparotomy followed by total abdominal and pelvic irradiation
Number of subjects: 166

Group type: COMPARATOR
Intervention: Group C (n = 57) - oral chlorambucil without second-look operation
Number of subjects: 166
Study: 29095478

Group type: EXPERIMENTAL
Intervention: Participatory physical and psychosocial workplace intervention (PIPPI)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 415
Study: 28807139

Group type: EXPERIMENTAL
Intervention: Mental health (MH) recognition in EMR
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Mental health (MH) service use
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: EMR documentation of MH diagnoses
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: EMR MH diagnosis
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Higher internal locus of control
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Poor physical health-related QOL
Number of subjects: 180
Study: 26565927

Group type: EXPERIMENTAL
Intervention: Intravitreous ranibizumab (0.5 mg)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Panretinal photocoagulation (PRP)
Number of subjects: 305
Study: 23095128

Group type: EXPERIMENTAL
Intervention: Ultrapro® mesh (Ethicon)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Vypro® mesh (Ethicon)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Prolene® light mesh (Ethicon)
Number of subjects: 144
Study: 21248668

Group type: EXPERIMENTAL
Intervention: CO2-enriched water immersion
Number of subjects: 25

Group type: COMPARATOR
Intervention: Normal spa water immersion
Number of subjects: 25
Study: 18465343

Group type: EXPERIMENTAL
Intervention: Oral pamidronate (150 mg twice daily for 4 years)
Number of subjects: 953

Group type: COMPARATOR
Intervention: No pamidronate (control group)
Number of subjects: 953
Study: 16540947

Group type: EXPERIMENTAL
Intervention: 4INJ group (n = 42) receiving four injections of methylprednisolone sodium succinate
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: 1INJ group (n = 42) receiving one injection of methylprednisolone followed by three injections of normal saline
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (n = 43) receiving four injections of normal saline
Number of subjects: 128
Study: 12669747

Group type: EXPERIMENTAL
Intervention: Spatial cuing effects with distractor interference
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spatial cuing effects without distractors
Number of subjects: 0
Study: 10630947

Group type: EXPERIMENTAL
Intervention: Intraosseous injection of 1.8 mL of 3% mepivacaine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Mock intraosseous injection
Number of subjects: 48
Study: 8922326

Group type: EXPERIMENTAL
Intervention: Study catheter (Berman catheter)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard selective catheter technique
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Study catheter
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 36
Study: 1391258

Group type: EXPERIMENTAL
Intervention: Chlorothiazide (diuretic therapy)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (no diuretics)
Number of subjects: 17
Study: 29448460

Group type: EXPERIMENTAL
Intervention: Statistical analysis of stress serrations and acoustic emission in AlMgScZr alloy
Number of subjects: 0
Study: 27583530

Group type: EXPERIMENTAL
Intervention: Ethicon Silk® 4/0
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: B. Braun Dafilon® 4/0
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: B. Braun Safil® 4/0
Number of subjects: 30
Study: 25360036

Group type: EXPERIMENTAL
Intervention: Geboes score (GS)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Modified Riley score (MRS)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Visual analogue scale (VAS)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Correlation between GS and VAS
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Correlation between MRS and VAS
Number of subjects: 49
Study: 23002698

Group type: EXPERIMENTAL
Intervention: Social interaction task
Number of subjects: 82

Group type: COMPARATOR
Intervention: Reading task
Number of subjects: 82
Study: 21182781

Group type: EXPERIMENTAL
Intervention: 8 mg intravenous dexamethasone
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 19339559

Group type: EXPERIMENTAL
Intervention: Accelerated perioperative care and rehabilitation protocol
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard protocol
Number of subjects: 87
Study: 16762982

Group type: EXPERIMENTAL
Intervention: 30 mg pioglitazone once daily for 4 weeks
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion of TNF-alpha (10 ng/100 mL forearm volume/min for 2 h)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 15217043

Group type: EXPERIMENTAL
Intervention: Impact of Event Scale (IES)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Social Support and Emotional Expressiveness
Number of subjects: 37
Study: 11375879

Group type: EXPERIMENTAL
Intervention: Stabilisation training combined with dynamic-static resistance training (group 3)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Stabilisation training (group 1)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Stabilisation training combined with dynamic resistance training (group 2)
Number of subjects: 59
Study: 8985221

Group type: EXPERIMENTAL
Intervention: Meningococcal polysaccharide vaccine
Number of subjects: 221

Group type: COMPARATOR
Intervention: Polysaccharide vaccine
Number of subjects: 221

Group type: COMPARATOR
Intervention: Conjugate vaccine
Number of subjects: 221
Study: 8115726

Group type: EXPERIMENTAL
Intervention: Perfluoropropane gas
Number of subjects: 340

Group type: COMPARATOR
Intervention: Silicone oil
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Group 1 (no prior vitrectomy)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Group 2 (prior vitrectomy)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: More than one operation
Number of subjects: 340
Study: 2892254

Group type: EXPERIMENTAL
Intervention: Nizatidine 30 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nizatidine 100 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nizatidine 300 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 8
Study: 29273494

Group type: EXPERIMENTAL
Intervention: Gow-Gates nerve block (GGNB)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Inferior alveolar nerve block (IANB)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Gow-Gates nerve block (GGNB) + Inferior alveolar nerve block (IANB)
Number of subjects: 150
Study: 27642053

Group type: EXPERIMENTAL
Intervention: Team training programme focused on crew resource management and checklist utilization in 16 intervention hospitals.
Number of subjects: 22779

Group type: COMPARATOR
Intervention: Control hospitals (15 hospitals) without the team training programme.
Number of subjects: 22779

Group type: COMPARATOR
Intervention: Comparison of surgical outcomes between intervention and control hospitals.
Number of subjects: 22779
Study: 24045086

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 22395850

Group type: EXPERIMENTAL
Intervention: Continuous stochastic resonance whole body vibration (SR‐WBV)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intermittent stochastic resonance whole body vibration (SR‐WBV)
Number of subjects: 50
Study: 20524910

Group type: EXPERIMENTAL
Intervention: Tiotropium bromide 18 µg once daily
Number of subjects: 5992

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5992
Study: 18519003

Group type: EXPERIMENTAL
Intervention: Nurse and GP partnership care based on Australian COPDX guidelines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care from GPs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nurse and GP partnership care
Number of subjects: 0
Study: 16009987

Group type: EXPERIMENTAL
Intervention: Knee laxity
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Proprioception
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Muscle strength
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Stabilometry (amplitude and average speed of center of pressure movements)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Subjective estimation of extremity function (measured on a visual analog scale)
Number of subjects: 36
Study: 13678868

Group type: EXPERIMENTAL
Intervention: Candesartan (titrated to 32 mg once daily)
Number of subjects: 7601

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7601
Study: 10543583

Group type: EXPERIMENTAL
Intervention: Megadose Vitamin C (1000 mg hourly for the first 6 hours, then 3 times daily thereafter)
Number of subjects: 715

Group type: COMPARATOR
Intervention: Control group (pain relievers and decongestants)
Number of subjects: 715
Study: 8903809

Group type: EXPERIMENTAL
Intervention: 30 mg ketorolac
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 50 mg meperidine
Number of subjects: 47

Group type: COMPARATOR
Intervention: Normal saline solution (control)
Number of subjects: 47
Study: 2070311

Group type: EXPERIMENTAL
Intervention: Split-virion vaccine (SVV)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Whole-virion vaccine (WVV)
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Both SVV and WVV
Number of subjects: 358
Study: 6354056

Group type: EXPERIMENTAL
Intervention: Opsite
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sofratulle
Number of subjects: 50
Study: 31524141

Group type: EXPERIMENTAL
Intervention: US-guided injection (n=23)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Blind injection (n=24)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study: 30638985

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg/day)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95

Group type: COMPARATOR
Intervention: Dexamethasone vs Placebo
Number of subjects: 95
Study: 28853992

Group type: EXPERIMENTAL
Intervention: Cookies containing 6% bay leaf powder (B6)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control cookies (CC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cookies containing 3% bay leaf powder (B3)
Number of subjects: 20
Study: 26376447

Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg, single dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 23711703

Group type: EXPERIMENTAL
Intervention: Artemisinin combination therapy (ACT) AS+SP
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Artemisinin combination therapy (ACT) AM+LF
Number of subjects: 207
Study: 21194892

Group type: EXPERIMENTAL
Intervention: 2.0-mm locking plates (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 2.0-mm nonlocking plates (group B)
Number of subjects: 50
Study: 19122552

Group type: EXPERIMENTAL
Intervention: Combined spinal and epidural anaesthesia (CSEA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Single shot spinal anaesthesia (SSSA)
Number of subjects: 70
Study: 17582033

Group type: EXPERIMENTAL
Intervention: Chest Pain Unit (CPU) care
Number of subjects: 1644

Group type: EXPERIMENTAL
Intervention: Standardised protocols for biochemical cardiac marker and exercise treadmill testing
Number of subjects: 1644
Study: 12872150

Group type: EXPERIMENTAL
Intervention: IFN-α (IFN) treatment
Number of subjects: 163

Group type: COMPARATOR
Intervention: No IFN treatment (Control)
Number of subjects: 163
Study: 11091498

Group type: EXPERIMENTAL
Intervention: G-CSF (arm A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GM-CSF (arm B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GM-CSF/G-CSF (arm C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All arms
Number of subjects: 60
Study: 9350159

Group type: EXPERIMENTAL
Intervention: Intramuscular dexamethasone (IMD)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Oral prednisone (OP)
Number of subjects: 42
Study: 8477212

Group type: EXPERIMENTAL
Intervention: Cefotaxime and gentamicin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin and gentamicin
Number of subjects: 40
Study: 3454368

Group type: EXPERIMENTAL
Intervention: Phenylephrine (PE) 2.5% and tropicamide 1.0% (Group A)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Phenylephrine (PE) 2.5%, tropicamide 0.5%, and cyclopentolate 0.5% (Group B)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Phenylephrine (PE) 1.0% and tropicamide 1.0% (Group C)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Saline 0.9% (Group D)
Number of subjects: 34
Study: 31865628

Group type: EXPERIMENTAL
Intervention: Cannabis (300-μg/kg delta-9-tetrahydrocannabinol)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30220290

Group type: EXPERIMENTAL
Intervention: Multisymptom tablet (containing paracetamol, pseudoephedrine hydrochloride, dextromethorphan hydrobromide, and chlorpheniramine maleate)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Multisymptom tablet
Number of subjects: 53
Study: 27941973

Group type: EXPERIMENTAL
Intervention: Intravenous furosemide (125-250mg/bid) plus hypertonic saline solution (HSS)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Repeated paracentesis
Number of subjects: 59
Study: 24888857

Group type: EXPERIMENTAL
Intervention: MBP+oral antibiotics
Number of subjects: 5473

Group type: COMPARATOR
Intervention: MBP alone
Number of subjects: 5473

Group type: COMPARATOR
Intervention: Oral antibiotics alone
Number of subjects: 5473

Group type: EXPERIMENTAL
Intervention: Overall evidence-based preparation
Number of subjects: 5473
Study: 22226313

Group type: EXPERIMENTAL
Intervention: Homeopathic medicines
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo homeopathy
Number of subjects: 28
Study: 20307657

Group type: EXPERIMENTAL
Intervention: Microdose (100 microg) of (14)C-drug administered orally
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Therapeutic dose (120mg) of fexofenadine administered orally
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Microdose (100 microg) of (14)C-drug administered intravenously
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Therapeutic dose (120mg) of fexofenadine administered with intravenous tracer dose (100 microg) of (14)C-drug
Number of subjects: 6
Study: 18593715

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 1295
Study: 15816442

Group type: EXPERIMENTAL
Intervention: Total mesorectal excision (TME) with adjuvant systemic chemotherapy and radiotherapy
Number of subjects: 210

Group type: COMPARATOR
Intervention: Total mesorectal excision (TME) with adjuvant stop-flow perfusion along with systemic chemotherapy
Number of subjects: 210
Study: 12177032

Group type: EXPERIMENTAL
Intervention: Insecticide-impregnated bednets
Number of subjects: 0
Study: 10947491

Group type: EXPERIMENTAL
Intervention: Raltitrexed
Number of subjects: 495

Group type: COMPARATOR
Intervention: 5FU + FA
Number of subjects: 495